Treatment sequencing and the benefits of DMTs
touchPANEL DISCUSSION for touchNEUROLOGY
Listen to a panel of leading multiple sclerosis (MS) experts discuss their perspectives on the benefits of disease-modifying therapies (DMTs) in MS, and current approaches to treatment sequencing.
The experts
Prof. Gavin Giovannoni (Chair), Blizard Institute, Queen Mary University of London, UK
Prof. Eva Havrdová, General Faculty Hospital, Charles University in Prague, Czech Republic
Prof. Patrick Vermersch, Lille University Hospital, France
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent educational grant…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.